Pregnancy complications in maternal's hyperthyroidisam and hypothyroidisam.

Baldzieva, Sanja and Jovevska, Svetlana and Ljupka, Lazareva (2023) Pregnancy complications in maternal's hyperthyroidisam and hypothyroidisam. Knowledge-International Journal, Vol.61 (4). pp. 759-766.

[thumbnail of PREGNANCY+COMPLICATIONS+IN+MATERNAL'S+HYPERTHYROIDISM+AND+HYPOTHYROIDISM.pdf] Text
PREGNANCY+COMPLICATIONS+IN+MATERNAL'S+HYPERTHYROIDISM+AND+HYPOTHYROIDISM.pdf

Download (903kB)
[thumbnail of Naslovna za Pregnancy comp.Vol. 61 No. 4 (2023)_ Knowledge in Practice _ KNOWLEDGE - International Journal.pdf] Text
Naslovna za Pregnancy comp.Vol. 61 No. 4 (2023)_ Knowledge in Practice _ KNOWLEDGE - International Journal.pdf

Download (1MB)

Abstract

Abstract: A healthy thyroid gland is a factor for successfully coping with the increased physiological demands of
pregnancy. Diseases of the thyroid gland, whether manifest or subclinical thyroid dysfunction, affect pregnancy at
all trimesters, especially in the first trimester. The fetal thyroid gland begins to produce thyroid hormones after the
18th week of gestation, therefore maternal thyroid hormones are necessary for normal development and growth of
the fetus in the first trimester. Maternal hyperthyroidism and hypothyroidism during pregnancy is a predictive factor
that increases feto-maternal and neonatal morbidity and mortality.
The objective is to determine the prevalence of thyroid disorders in the mother and their relationship with the fetal
outcome, as well as to change the management of the patients in the direction of achieving an optimal serum level of
thyroid-stimulating hormone.
Laboratory tests are used to assess thyroid function in 69 patients and data from questionnaires obtained by a survey
method for: birth weight of live births from successful pregnancies, number of spontaneous losses of early
pregnancy, personal and family history of thyroid disease and obstetric history.
The treatment of hypothyroidism, subclinical hypothyroidism and hyperthyroidism show a positive result where no
deviation is noted in the birth weight of a fetus from a mother with a personal history of thyroid disease that has
been treated and without thyroid pathology. The role of AntiTPO Ab still remains a field of research where in our
case no significant difference was recorded between the exposed and investigated group. The average gestational
week of spontaneous abortion was 8 weeks of gestation. The average value of TSH in patients who had a
miscarriage in early pregnancy was 2.55 mU/L, SD of TSH 1.54 mU/L, where a significant difference was obtained
from the value of TSH in the group of subjects without spontaneous abortion (p=0.054)
Any change in the level of thyroid hormones in the mother affects the feto-maternal complex, and the determination
of serum TSH should be included in the routine investigation of thyroid dysfunction. In this way, spontaneous early
pregnancy loss due to thyroid disease will be prevented and women who are at risk for other pregnancy
complications will be identified and recognized. Through early screening, therapy would be initiated on time: before
conception or very early in the first trimester.
Keywords: thyroid stimulating hormone (TSH), spontaneous abortion, hyperthyroidism, hypothyroidism

Item Type: Article
Subjects: Medical and Health Sciences > Clinical medicine
Divisions: Faculty of Medical Science
Depositing User: Sanja Baldzieva
Date Deposited: 03 Dec 2024 13:19
Last Modified: 03 Dec 2024 13:19
URI: https://eprints.ugd.edu.mk/id/eprint/35145

Actions (login required)

View Item View Item